3[2]Tacev T,Ptackova B,Strnad V.Californium-252(252Cf)versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.Strahlenther Onkol,2003,179:377-384.
4[3]Maruyama Y,Nagell V,Yoneda J.A review of californium-252 neutron brachytherapy for cervical cancer.Cancer,1991,68:1189-1197.
5[5]Maruyama Y,Mesina J,Yudelev M,et al.New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.Strahlenther Onkol,1994,170:253-263.
6[6]Toita T,Kakinohana Y,Ogawa K,et al.Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer:analysis of dose and fractionation schedule.Int J Radiat Oncol Biol Phys,2003,56:1344-1353.
3Nagai Y, Toita T, Wakayama A, et al. Concurrent chemoradio- therapy with paclitaxel and cisplatin for adenocarcinoma of the cervical[J]. Anticancer Res, 2012,32(4):1475-1479.
4Nogueira A, Catarino R, Faustino I, et al. Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy [ J ]. Gene, 2012, 504 (2) :279-283.
5Tharavichitkul E, Klunkin P, Lorvidhaya V, et al. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai,Thailand [ J ].J Radiat Res, 2012,53 (2) : 281-287.
